Artificial-intelligence-based models of protein structure could be improved by incorporating data from pharmaceutical companies.Credit: Miyako Nakamura/Getty For drug…
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends…